Chromium Picolinate Supplementation Attenuates Body Weight Gain And Increases Insulin Sensitivity In Subjects With Type 2 Diabetes
Notes for this study:
|Number of Subjects
Supplementation of 1,000µg chromium (as picolinate) alongside sulfonylurea therapy for 10 months in type II diabetic persons noted that, relative to a sulfonylurea/placebo pairing, that chromium resulted in an additional decrease in glucose and free fatty acids in serum without any other significant alterations.
There appeared to be an anti-obese effect of chromium, as the 0.9kg weight gain with sulfonylurea therapy was mitigated with chromium coingestion.